Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter? Frontiers in Oncology

P. Monti, P. Menichini, A. Speciale, G. Cutrona, F. Fais, E. Taiana, A. Neri, Riccardo Bomben, M. Gentile, V. Gattei, M. Ferrarini, F. Morabito, G. Fronza

Research output: Contribution to journalArticlepeer-review

Abstract

The human TP53 locus, located on the short arm of chromosome 17, encodes a tumour suppressor protein which functions as a tetrameric transcription factor capable of regulating the expression of a plethora of target genes involved in cell cycle arrest, apoptosis, DNA repair, autophagy, and metabolism regulation. TP53 is the most commonly mutated gene in human cancer cells and TP53 germ-line mutations are responsible for the cancer-prone Li-Fraumeni syndrome. When mutated, the TP53 gene generally presents missense mutations, which can be distributed throughout the coding sequence, although they are found most frequently in the central DNA binding domain of the protein. TP53 mutations represent an important prognostic and predictive marker in cancer. The presence of a TP53 mutation does not necessarily imply a complete P53 inactivation; in fact, mutant P53 proteins are classified based on the effects on P53 protein function. Different models have been used to explore these never-ending facets of TP53 mutations, generating abundant experimental data on their functional impact. Here, we briefly review the studies analysing the consequences of TP53 mutations on P53 protein function and their possible implications for clinical outcome. The focus shall be on Chronic Lymphocytic Leukemia (CLL), which also has generated considerable discussion on the role of TP53 mutations for therapy decisions. © Copyright © 2020 Monti, Menichini, Speciale, Cutrona, Fais, Taiana, Neri, Bomben, Gentile, Gattei, Ferrarini, Morabito and Fronza.
Original languageEnglish
Article number593383
Number of pages8
JournalFront. Oncol.
Volume10
DOIs
Publication statusPublished - 2020

Keywords

  • chronic lymphocytic leukemia
  • clinical impact
  • P53 protein function
  • reactivation of P53
  • TP53 mutations

Fingerprint Dive into the research topics of 'Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter? Frontiers in Oncology'. Together they form a unique fingerprint.

Cite this